Literature DB >> 2544511

Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme.

M Fujimoto1, D W Fults, G A Thomas, Y Nakamura, M P Heilbrun, R White, J L Story, S L Naylor, K S Kagan-Hallet, P J Sheridan.   

Abstract

Recessive mutations, revealed by loss of the wild-type allele, have been associated with the development of a variety of cancers in children and adults. Polymorphic chromosome 10 markers were used to screen paired tumor and lymphocyte DNA samples in 13 patients with glioblastoma multiforme. Ten patients showed loss of constitutional heterozygosity in the tumor samples. This finding suggests that a recessive gene involved in the development of glioblastoma multiforme is present on chromosome 10.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544511     DOI: 10.1016/0888-7543(89)90302-9

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  22 in total

Review 1.  Molecular genetics of neurological tumours.

Authors:  R Y Chung; B R Seizinger
Journal:  J Med Genet       Date:  1992-06       Impact factor: 6.318

2.  Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas.

Authors:  J H Kim; S H Lee; C H Rhee; S Y Park; J H Lee
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

3.  Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10.

Authors:  D M Schonk; H J Kuijpers; E van Drunen; C H van Dalen; A H Geurts van Kessel; R Verheijen; F C Ramaekers
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

4.  Loss of heterozygosity for DNA polymorphisms mapping to chromosomes 10 and 17 and prognosis in patients with gliomas.

Authors:  C E Jones; M B Davis; J L Darling; J F Geddes; D G Thomas; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

5.  Alterations in tumour suppressor gene p53 in human gliomas from Indian patients.

Authors:  Poornima Phatak; S Kalai Selvi; T Divya; A S Hegde; Sridevi Hegde; Kumaravel Somasundaram
Journal:  J Biosci       Date:  2002-12       Impact factor: 1.826

6.  Non-enhancing de novo glioblastoma: report of two cases.

Authors:  Aaron A Cohen-Gadol; Michael L DiLuna; Sergei I Bannykh; Joseph M Piepmeier; Dennis D Spencer
Journal:  Neurosurg Rev       Date:  2004-07-28       Impact factor: 3.042

Review 7.  Genetic alterations in glioma and medulloblastoma.

Authors:  B K Rasheed; S H Bigner
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

8.  Loss of constitutional heterozygosity in human astrocytomas.

Authors:  E Van de Kelft; K De Boulle; P Willems; J J Martin; P Selosse; B Van der Auwera
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

9.  Aggressive oligodendroglioma predicted by chromosome 10 restriction fragment length polymorphism analysis. Case study.

Authors:  J K Wu; R D Folkerth; Z Ye; B T Darras
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

Review 10.  Molecular biology of pediatric gliomas.

Authors:  C Raffel
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.